Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Renal Failure

Free Subscription Articles published in J Am Soc Nephrol Retrieve available abstracts of 101 articles: HTML format

Single Articles

October 2026
1. LIU J, Jin L, Luo F, Zhou S, et al
   Comparative Cardiovascular Outcomes of Lanthanum Carbonate and Sevelamer in Dialysis.
   J Am Soc Nephrol. 2026 Oct 6. doi: 10.1681/ASN.0000001289.
   PubMed     Abstract available
   
   
   September 2026
2. LEE SA, Aulakh G, Chandraker A
   Microplastics and Nanoplastics in Dialysis Patients: An Emerging Safety Question in a Vulnerable Population.
   J Am Soc Nephrol. 2026 Sep 22. doi: 10.1681/ASN.0000001288.
   PubMed    
   
   
   
3. NISSENSON AR, Hegbrant J, Maddux FW, Strippoli GFM, et al
   Hemodialysis Care: Evolving to Enhance Patient-Level Outcomes.
   J Am Soc Nephrol. 2026 Sep 22. doi: 10.1681/ASN.0000001286.
   PubMed     Abstract available
   
   
   
4. BLANKESTIJN PJ, Roos S, Barth C, Bots ML, et al
   Hemodiafiltration: Clinical Practice of Today and a Look into the Future.
   J Am Soc Nephrol. 2026 Sep 22. doi: 10.1681/ASN.0000001282.
   PubMed     Abstract available
   
   
   
5. FENG Y, Yiu WH, Lam DK, Ma J, et al
   Translocator Protein and Mitochondrial Dysfunction in Chronic Kidney Disease?.
   J Am Soc Nephrol. 2026 Sep 21. doi: 10.1681/ASN.0000001262.
   PubMed     Abstract available
   
   
   
6. MOLONEY BM, Mc Causland FR
   beta-Blockers in Hemodialysis: Does Dialyzability Matter?
   J Am Soc Nephrol. 2026 Sep 17. doi: 10.1681/ASN.0000001253.
   PubMed    
   
   
   
7. LE D, Ahearn L, Wilk AS, Udani S, et al
   Assessment of Medicare Advantage Stars Measures: Impact on Kidney Care Quality and Future Opportunities.
   J Am Soc Nephrol. 2026;37:2065-2073.
   PubMed     Abstract available
   
   
   
8. MOLNAR AO, Kang Y, Nash DM, Li L, et al
   Effect of a Change in the Eligibility Criteria for Multidisciplinary Kidney Care.
   J Am Soc Nephrol. 2026;37:1954-1968.
   PubMed     Abstract available
   
   
   
9. CATANESE B, Miller C, Wolf M, Edmonston D, et al
   Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure.
   J Am Soc Nephrol. 2026;37:1992-2003.
   PubMed     Abstract available
   
   
   August 2026
10. MOORE E, Haak J, Fernadez P, Beardsley S, et al
    Dialysis Access without Guesswork: A Digital Navigation Framework for Improved Access Technique.
    J Am Soc Nephrol. 2026 Aug 31. doi: 10.1681/ASN.0000001267.
    PubMed    
    
    
    
11. MCCOY I, Liu KD, Siew E, Tuot DS, et al
    Dialysis Discontinuation Rates at Low Levels of Kidney Function in Patients with Acute Kidney Injury on Intermittent Hemodialysis.
    J Am Soc Nephrol. 2026 Aug 25. doi: 10.1681/ASN.0000001245.
    PubMed     Abstract available
    
    
    
12. ZHOU Z, Yang B
    Joint Interpretation of Long-Chain and Very Long-Chain Sphingolipid Associations with Mortality in Hemodialysis.
    J Am Soc Nephrol. 2026 Aug 21. doi: 10.1681/ASN.0000001211.
    PubMed    
    
    
    
13. LIDGARD B, Jensen PN, Sitlani CM, Lemaitre RN, et al
    Authors' Reply: Joint Interpretation of Long-Chain and Very Long-Chain Sphingolipid Associations with Mortality in Hemodialysis.
    J Am Soc Nephrol. 2026 Aug 21. doi: 10.1681/ASN.0000001212.
    PubMed    
    
    
    
14. CHEN J, Jiang Y
    Sphingolipids and Death in Hemodialysis: A Data Inconsistency and Unaddressed Competing Risk.
    J Am Soc Nephrol. 2026 Aug 20. doi: 10.1681/ASN.0000001226.
    PubMed    
    
    
    
15. GARG AX, Al-Jaishi AA, Conklin AI, McKenzie SQ, et al
    Alterations to the Consent Process in Five Pragmatic Randomized Trials of Routine Hemodialysis Care.
    J Am Soc Nephrol. 2026 Aug 20. doi: 10.1681/ASN.0000001251.
    PubMed     Abstract available
    
    
    
16. LIDGARD B, Jensen PN, Zelnick LR
    Authors' Reply: Sphingolipids and Death in Hemodialysis: A Data Inconsistency and Unaddressed Competing Risk.
    J Am Soc Nephrol. 2026 Aug 20. doi: 10.1681/ASN.0000001227.
    PubMed    
    
    
    
17. STRIPPOLI GFM, Tripepi G, Canaud B, Stuard S, et al
    Hemodiafiltration versus High-flux Hemodialysis and Risk of Mortality: A Multinational Target Trial Emulation?.
    J Am Soc Nephrol. 2026 Aug 13. doi: 10.1681/ASN.0000001225.
    PubMed     Abstract available
    
    
    
18. ADLER JT, Kuk AE, Drewry KM, Nguyen KH, et al
    Medicare Advantage and Access to Living Donor Kidney Transplantation among Older Patients Receiving Dialysis.
    J Am Soc Nephrol. 2026 Aug 5. doi: 10.1681/ASN.0000001209.
    PubMed     Abstract available
    
    
    July 2026
19. SHANG Y, Jin J, He Q
    Dialysis Day beta -Blocker Exposure in Hemodialysis : What Exactly Was Emulated?
    J Am Soc Nephrol. 2026 Jul 28. doi: 10.1681/ASN.0000001179.
    PubMed    
    
    
    
20. ETEMADI A, Winkelmayer WC, Montez-Rath ME, Chang TI, et al
    Authors' Reply: Dialysis Day beta-Blocker Exposure in Hemodialysis: What Exactly Was Emulated?
    J Am Soc Nephrol. 2026 Jul 28. doi: 10.1681/ASN.0000001180.
    PubMed    
    
    
    
21. HSU CM, Miskulin DC
    Influenza Vaccination in Dialysis: New Technologies for a Vulnerable Population.
    J Am Soc Nephrol. 2026 Jul 24. doi: 10.1681/ASN.0000001185.
    PubMed    
    
    
    
22. STANAWAY IB, Costa IPD, Davies SJ, Perl J, et al
    Correction to: Genetic Variation and Ultrafiltration with Peritoneal Dialysis: A Genome-Wide Association Study.
    J Am Soc Nephrol. 2026 Jul 22. doi: 10.1681/ASN.0000001222.
    PubMed    
    
    
    June 2026
23. QUINN RR, Oliver MJ, Wald R, Hiremath S, et al
    Comparing Catheters to Fistulas in Older Patients Starting Hemodialysis (ACCESS HD).
    J Am Soc Nephrol. 2026 Jun 22. doi: 10.1681/ASN.0000001160.
    PubMed     Abstract available
    
    
    
24. WILK AS, Drewry KM
    Fiscal Impact of Public Policy on Costs of the Medicare ESRD Program.
    J Am Soc Nephrol. 2026 Jun 9. doi: 10.1681/ASN.0000001156.
    PubMed    
    
    
    
25. WILKIE M, Heimburger O, de Leon C, Carlsson O, et al
    Ultrafiltration and Sodium Removal in Steady Concentration Peritoneal Dialysis: A Prospective, Multicenter, Randomized, Crossover Study.
    J Am Soc Nephrol. 2026 Jun 4. doi: 10.1681/ASN.0000001152.
    PubMed     Abstract available
    
    
    
26. WONG SPY, Schell JO, Bursic AE, Butler CR, et al
    ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure.
    J Am Soc Nephrol. 2026;37:1291-1303.
    PubMed     Abstract available
    
    
    
27. WEISS JW, Hall R, Saeed F, Callahan MB, et al
    Executive Summary of ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure.
    J Am Soc Nephrol. 2026;37:1287-1290.
    PubMed     Abstract available
    
    
    May 2026
28. SCHELL JO, Schwarze ML, Arnold RM, Moss AH, et al
    Applying a Better Conversations Framework to Dialysis Decision-Making for Patients with Advanced CKD.
    J Am Soc Nephrol. 2026 May 29. doi: 10.1681/ASN.0000001163.
    PubMed    
    
    
    
29. ETEMADI A, Liu S, Winkelmayer WC, Montez-Rath ME, et al
    Nondialyzable versus Dialyzable Beta-Blockers in Hemodialysis: A Target Trial Emulation Study.
    J Am Soc Nephrol. 2026 May 20. doi: 10.1681/ASN.0000001147.
    PubMed     Abstract available
    
    
    
30. BIEBER B, Aragon M, D'Alessandri-Silva C, Repeck K, et al
    Risk of Vascular Access-Related Infections in Home Versus In-Center Hemodialysis.
    J Am Soc Nephrol. 2026 May 5. doi: 10.1681/ASN.0000001140.
    PubMed    
    
    
    April 2026
31. SAUM KL, Pennathur S
    Sphingolipids and Mortality in Hemodialysis: Innocent Bystanders or Causal Culprits?
    J Am Soc Nephrol. 2026 Apr 27. doi: 10.1681/ASN.0000001110.
    PubMed    
    
    
    
32. BRIGGS JP, Hostetter TH
    For-Profit Dialysis and Academic Neglect Are Undermining Dialysis Research in the United States.
    J Am Soc Nephrol. 2026 Apr 20. doi: 10.1681/ASN.0000001128.
    PubMed    
    
    
    
33. DAVIS JW, Layton JB, Sahrmann JM, Nickel KB, et al
    Comparative Effectiveness of Different Influenza Vaccine Formulations among Patients Undergoing Maintenance Hemodialysis.
    J Am Soc Nephrol. 2026 Apr 13. doi: 10.1681/ASN.0000001099.
    PubMed     Abstract available
    
    
    
34. SHAH AD, Liao Y, Lee Y, Mor V, et al
    Untangling Dialysis Received in a Nursing Home from Home Hemodialysis in the Community.
    J Am Soc Nephrol. 2026 Apr 2. doi: 10.1681/ASN.0000001109.
    PubMed    
    
    
    March 2026
35. CHERTOW GM, Agarwal R, Burke SK, Luo W, et al
    Comparing Vadadustat and Darbepoetin in Maintenance Dialysis with CKD-Related Anemia: A Win Statistics Analysis.
    J Am Soc Nephrol. 2026 Mar 17. doi: 10.1681/ASN.0000001090.
    PubMed    
    
    
    
36. SHUKLA AM, Scheiffele G, Huang W, Campbell-Montalvo R, et al
    Correction to: Race- and Ethnicity-Related Disparities in Predialysis Nephrology Care, Kidney Disease Education, and Home Dialysis Utilization.
    J Am Soc Nephrol. 2026 Mar 5. doi: 10.1681/ASN.0000001075.
    PubMed    
    
    
    February 2026
37. LIDGARD B, Bansal N, Lemaitre R
    Authors' Reply: Dialysis Dose and Flux as Potential Effect Modifiers of Sphingolipid-Mortality Associations.
    J Am Soc Nephrol. 2026 Feb 25. doi: 10.1681/ASN.0000001034.
    PubMed    
    
    
    
38. ZHAO Q, Yang Y, Liu X, Chen J, et al
    Dialysis Dose and Flux as Potential Effect Modifiers of Sphingolipid-Mortality Associations.
    J Am Soc Nephrol. 2026 Feb 25. doi: 10.1681/ASN.0000001033.
    PubMed    
    
    
    
39. LEAGUE R, McDevitt RC
    The Fiscal Impact of the Medicare Secondary Payer Act for End-Stage Renal Disease.
    J Am Soc Nephrol. 2026 Feb 3. doi: 10.1681/ASN.0000001028.
    PubMed     Abstract available
    
    
    December 2025
40. JAIN N, Dhamelia P, Arthur JM
    Fungal DNA in Circulation: A Sleuth's Clue to Predict Cardiovascular Risk for Hemodialysis Patients.
    J Am Soc Nephrol. 2025 Dec 29. doi: 10.1681/ASN.0000000993.
    PubMed    
    
    
    
41. KNAPP CD, Li S, Kou C, Wetmore JB, et al
    Peritoneal Dialysis Initiation Patterns by Health Service Area during an Era of Expansion.
    J Am Soc Nephrol. 2025 Dec 26. doi: 10.1681/ASN.0000000989.
    PubMed     Abstract available
    
    
    
42. WALTHER CP, Nair AP
    Management of Dialysis for Patients Receiving Mechanical Circulatory Support.
    J Am Soc Nephrol. 2025 Dec 24. doi: 10.1681/ASN.0000001013.
    PubMed     Abstract available
    
    
    
43. LIDGARD B, Hoofnagle AN, Zelnick LR, de Boer IH, et al
    Association of Sphingolipids with All-Cause and Cardiovascular Death in Patients with Kidney Failure Treated with Maintenance Hemodialysis.
    J Am Soc Nephrol. 2025 Dec 19. doi: 10.1681/ASN.0000000982.
    PubMed     Abstract available
    
    
    
44. KUCIRKA LM, Boggess KA, Wood ME, Quist-Nelson J, et al
    Severe Maternal Morbidity and Long-Term Kidney Outcomes among Pregnant Women Receiving Maintenance Dialysis.
    J Am Soc Nephrol. 2025 Dec 1. doi: 10.1681/ASN.0000000949.
    PubMed    
    
    
    October 2025
45. MAYNE KJ, Herrington WG
    "Hi"s and "Lo"s of Targeting Serum Phosphate Levels in Hemodialysis.
    J Am Soc Nephrol. 2025 Oct 30. doi: 10.1681/ASN.0000000903.
    PubMed    
    
    
    
46. KAPLAN JM, Niu J, Ho V, Winkelmayer WC, et al
    Correction to: A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis.
    J Am Soc Nephrol. 2025 Oct 15. doi: 10.1681/ASN.0000000918.
    PubMed    
    
    
    August 2025
47. ALVARADO F, Hall RK
    Peer Support for Hemodialysis Patients: Moving from Effectiveness to Implementation.
    J Am Soc Nephrol. 2025 Aug 25. doi: 10.1681/ASN.0000000839.
    PubMed    
    
    
    
48. SUMIDA K, Mallisetty Y, Chiu CY, Han Z, et al
    Circulating Mycobiota Signatures and Cardiovascular Mortality among Patients Undergoing Hemodialysis.
    J Am Soc Nephrol. 2025 Aug 11. doi: 10.1681/ASN.0000000829.
    PubMed     Abstract available
    
    
    July 2025
49. CHENG FWT, Xu W, Tang SCW, Wan EYF, et al
    Authors' Reply: Statins' Efficacy Controversy in Kidney Failure: Reassessing Safety and Dialysis Stratification Need.
    J Am Soc Nephrol. 2025 Jul 22. doi: 10.1681/ASN.0000000800.
    PubMed    
    
    
    
50. LIN J, Luo L
    Statins' Efficacy Controversy in Kidney Failure: Reassessing Safety and Dialysis Stratification Need.
    J Am Soc Nephrol. 2025 Jul 22. doi: 10.1681/ASN.0000000798.
    PubMed    
    
    
    
51. CHRISTOU CD, Jaradat F, Olsburgh J, Sacks S, et al
    Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury.
    J Am Soc Nephrol. 2025 Jul 22. doi: 10.1681/ASN.0000000826.
    PubMed     Abstract available
    
    
    
52. STANAWAY IB, Costa IPD, Davies SJ, Perl J, et al
    Genetic Variation and Ultrafiltration with Peritoneal Dialysis: A Genome-Wide Association Study.
    J Am Soc Nephrol. 2025 Jul 16. doi: 10.1681/ASN.0000000803.
    PubMed     Abstract available
    
    
    
53. KLEIN KR, Flythe JE
    Time to Plan for Continuous Glucose Monitoring in Dialysis-Dependent Kidney Failure.
    J Am Soc Nephrol. 2025 Jul 10. doi: 10.1681/ASN.0000000794.
    PubMed    
    
    
    
54. EDMONSTON D, Isakova T, Dember LM, Waymyers S, et al
    Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled Trial.
    J Am Soc Nephrol. 2025 Jul 10. doi: 10.1681/ASN.0000000765.
    PubMed     Abstract available
    
    
    June 2025
55. GOLESTANEH L, Melamed ML, Cavanaugh KL
    Authors' Reply: Peer Mentorship's Paradox in Dialysis: Neutral Overall but Lifesaving for Black Patients: Toward Equity-Driven Trial Designs.
    J Am Soc Nephrol. 2025 Jun 27. doi: 10.1681/ASN.0000000782.
    PubMed    
    
    
    
56. ZHANG Y, Wang K, Yang L
    Peer Mentorship's Paradox in Dialysis: Neutral Overall but Lifesaving for Black Patients: Toward Equity-Driven Trial Designs.
    J Am Soc Nephrol. 2025 Jun 27. doi: 10.1681/ASN.0000000781.
    PubMed    
    
    
    
57. BLANKESTIJN PJ
    Do Medium Cut-Off Dialyzers Offer Any Clinical Benefit or Should We Focus on Hemodiafiltration?
    J Am Soc Nephrol. 2025 Jun 27. doi: 10.1681/ASN.0000000777.
    PubMed    
    
    
    
58. DAUGIRDAS JT
    Ancillary Holographic No-Touch Control of Hemodialysis Machine Settings.
    J Am Soc Nephrol. 2025 Jun 26. doi: 10.1681/ASN.0000000807.
    PubMed    
    
    
    
59. SHI KX, Tuot DS
    Telemedicine for Hemodialysis Care Delivery: Value Added?
    J Am Soc Nephrol. 2025 Jun 5. doi: 10.1681/ASN.0000000755.
    PubMed    
    
    
    April 2025
60. GOLESTANEH L, Kim RS, Roach C, Norris KC, et al
    Effect of Peer Mentorship on Hospitalizations among Patients Receiving Maintenance Hemodialysis: A Pragmatic Randomized Controlled Trial.
    J Am Soc Nephrol. 2025 Apr 15. doi: 10.1681/ASN.0000000709.
    PubMed     Abstract available
    
    
    
61. LAZARUS B, Davies SJ, Polkinghorne KR
    Volume Assessment in Patients Undergoing Long-Term Dialysis.
    J Am Soc Nephrol. 2025 Apr 7. doi: 10.1681/ASN.0000000724.
    PubMed     Abstract available
    
    
    
62. BABROUDI S, Tighiouart H, Weiner DE, Neyra JA, et al
    Association of Social Risk Factors with Kidney Function Recovery among Patients with Acute Kidney Injury Receiving Outpatient Dialysis.
    J Am Soc Nephrol. 2025 Apr 2. doi: 10.1681/ASN.0000000692.
    PubMed    
    
    
    
63. MEYER TW
    Increasing the Removal of Large Solutes by Kidney Replacement Therapy.
    J Am Soc Nephrol. 2025;36:734-743.
    PubMed     Abstract available
    
    
    March 2025
64. DE BOER IH, Anderson LD, Ashford NK, Ayers E, et al
    Glycemia Assessed by Continuous Glucose Monitoring among People Treated with Maintenance Dialysis.
    J Am Soc Nephrol. 2025 Mar 21. doi: 10.1681/ASN.0000000693.
    PubMed     Abstract available
    
    
    
65. KOJIMA S, Usui N, Uehata A, Inatsu A, et al
    Acute Effect of Moderate-Intensity Interval Intradialytic Exercise on Cerebral Oxygenation in Hemodialysis Patients: A Randomized Crossover Trial.
    J Am Soc Nephrol. 2025 Mar 12. doi: 10.1681/ASN.0000000672.
    PubMed     Abstract available
    
    
    
66. LIM JH, Seo YJ, Jeon Y, Jeon YH, et al
    Expanded Hemodialysis with Theranova Dialyzer and Residual Kidney Function in Incident Hemodialysis Patients.
    J Am Soc Nephrol. 2025 Mar 4. doi: 10.1681/ASN.0000000655.
    PubMed     Abstract available
    
    
    February 2025
67. VIJAYAN A, Heung M, Awdishu L, Babroudi S, et al
    ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury.
    J Am Soc Nephrol. 2025 Feb 27. doi: 10.1681/ASN.0000000646.
    PubMed    
    
    
    
68. ANDREWS TD, Day GS, Irani SR, Kanekiyo T, et al
    Uremic Toxins, Chronic Kidney Disease, and Cognitive Dysfunction.
    J Am Soc Nephrol. 2025 Feb 26. doi: 10.1681/ASN.0000000675.
    PubMed     Abstract available
    
    
    
69. LAZARUS B, Lok CE, Moist L, Polkinghorne KR, et al
    Strategies to Prevent Hemodialysis Catheter Dysfunction.
    J Am Soc Nephrol. 2025 Feb 20. doi: 10.1681/ASN.0000000666.
    PubMed     Abstract available
    
    
    
70. WATNICK S, McNamara E, Weiner DE
    Better Dialysis Care in the United States Requires New Payment Policy: No Patient Left Behind.
    J Am Soc Nephrol. 2025 Feb 14. doi: 10.1681/ASN.0000000663.
    PubMed    
    
    
    January 2025
71. SUN Y, Huang Q, Sun J, Zhou H, et al
    MAIT Cell-Mediated Immune Mechanisms of Dialysis-Induced Peritoneal Fibrosis and Therapeutic Targeting.
    J Am Soc Nephrol. 2025 Jan 28. doi: 10.1681/ASN.0000000627.
    PubMed     Abstract available
    
    
    
72. NIU J, Rosales O, Oluyomi A, Lew SQ, et al
    Utilization of Telemedicine for Patients Receiving In-center Hemodialysis in the United States.
    J Am Soc Nephrol. 2025 Jan 16. doi: 10.1681/ASN.0000000619.
    PubMed     Abstract available
    
    
    December 2024
73. BONNET C, Torreggiani M, Bianco L, Amiard F, et al
    Autopsy of a Hemodialysis Machine: Potential for Recycling at the End of the Life Cycle.
    J Am Soc Nephrol. 2024 Dec 13. doi: 10.1681/ASN.0000000584.
    PubMed     Abstract available
    
    
    November 2024
74. HAREL Z, Smyth B, Badve SV, Blum D, et al
    Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial.
    J Am Soc Nephrol. 2024 Nov 4. doi: 10.1681/ASN.0000000000000495.
    PubMed     Abstract available
    
    
    October 2024
75. KORTL T, Hankowitz N, Stengel L, Pfeuffer O, et al
    In Vitro Simulation of Hemodialysis Reveals Hemodialysis-Associated Pro-Arrhythmic Effects in a Human Cardiomyocyte Model.
    J Am Soc Nephrol. 2024 Oct 25. doi: 10.1681/ASN.0000000563.
    PubMed    
    
    
    September 2024
76. SHUKLA AM, Scheiffele G, Huang W, Campbell-Montalvo R, et al
    Race-and Ethnicity-Related Disparities in Predialysis Nephrology Care, Kidney Disease Education, and Home Dialysis Utilization.
    J Am Soc Nephrol. 2024 Sep 4. doi: 10.1681/ASN.0000000000000489.
    PubMed     Abstract available
    
    
    
77. KIMMEL PL, Fwu CW, Nolin TD, Schulman IH, et al
    Opioid Prescriptions for US Patients Undergoing Long-Term Dialysis or with Kidney Transplant from 2011 to 2020.
    J Am Soc Nephrol. 2024 Sep 3. doi: 10.1681/ASN.0000000000000478.
    PubMed     Abstract available
    
    
    August 2024
78. DEVUYST O
    Aquaporin-1 and Osmosis: From Physiology to Precision in Peritoneal Dialysis.
    J Am Soc Nephrol. 2024 Aug 26. doi: 10.1681/ASN.0000000000000496.
    PubMed     Abstract available
    
    
    
79. ROBERTS GV, Jefferson NM, Picillo R, Torreggiani M, et al
    Patient, Nurse, and Physician Perspectives on Personalized, Incremental Hemodialysis.
    J Am Soc Nephrol. 2024 Aug 12. doi: 10.1681/ASN.0000000000000467.
    PubMed    
    
    
    
80. REDDY YNV, O'Hare AM, Edwards D, Hall R, et al
    Defining, Understanding, and Addressing Postdialysis Fatigue: Takeaways from a Scientific Workshop Hosted by the National Institutes of Health.
    J Am Soc Nephrol. 2024;35:1130-1133.
    PubMed    
    
    
    
81. HIMMELFARB J, Ratner BD
    An Innovation Ecosystem: The Center for Dialysis Innovation (CDI).
    J Am Soc Nephrol. 2024;35:1119-1122.
    PubMed    
    
    
    July 2024
82. PAJEWSKI NM, Beddhu S, Bress AP, Chang TI, et al
    The Legacy Effect of Intensive versus Standard Blood Pressure Control on the Incidence of Dialysis or Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 30. doi: 10.1681/ASN.0000000000000459.
    PubMed     Abstract available
    
    
    
83. GUPTA A, Holloway P, Young K, Villwock J, et al
    Changes in Olfactory and Cognitive Function after Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 9. doi: 10.1681/ASN.0000000000000456.
    PubMed    
    
    
    
84. PINTER J, Smyth B, Jardine M
    Authors' Reply: Dialysate Sodium and Mortality: One Size Does Not Fit All.
    J Am Soc Nephrol. 2024;35:977.
    PubMed    
    
    
    
85. HECKING M, Karaboyas A, Krenn S, Mussnig S, et al
    Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?
    J Am Soc Nephrol. 2024;35:972-973.
    PubMed    
    
    
    
86. FERNANDES G, Pochet JM, Labriola L
    Dialysate Sodium and Mortality: One Size Does Not Fit All.
    J Am Soc Nephrol. 2024;35:976.
    PubMed    
    
    
    
87. LI Y, Menon G, Long JJ, Chen Y, et al
    Neighborhood Racial and Ethnic Segregation and the Risk of Dementia in Older Adults Living with Kidney Failure.
    J Am Soc Nephrol. 2024;35:936-948.
    PubMed    
    
    
    
88. PATZER RE
    Bridging Racial Disparities in Access to Kidney Transplantation in the United States: Glass Part-Empty or Part-Full?
    J Am Soc Nephrol. 2024;35:959-961.
    PubMed    
    
    
    June 2024
89. PINTER J, Jardine M, Canaud B, Genser B, et al
    Authors' Reply: Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?
    J Am Soc Nephrol. 2024 Jun 6. doi: 10.1681/ASN.0000000000000376.
    PubMed    
    
    
    
90. DEGRAAUW J, Wong SPY
    Engaging Patients in Decision Making about Treatment of Kidney Failure: The Art and Science of Communication.
    J Am Soc Nephrol. 2024;35:673-675.
    PubMed    
    
    
    May 2024
91. ISMAIL S, Funk MJ, Flythe JE
    Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.
    J Am Soc Nephrol. 2024 May 20. doi: 10.1681/ASN.0000000000000386.
    PubMed    
    
    
    
92. HUNG KC, Chao CT
    Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.
    J Am Soc Nephrol. 2024 May 20. doi: 10.1681/ASN.0000000000000385.
    PubMed    
    
    
    
93. MCINTYRE CW
    Update on Hemodialysis-Induced Multiorgan Ischemia: Brains and Beyond.
    J Am Soc Nephrol. 2024;35:653-664.
    PubMed     Abstract available
    
    
    April 2024
94. MCALISTER S, Talbot B, Knight J, Blair S, et al
    The Carbon Footprint of Peritoneal Dialysis in Australia.
    J Am Soc Nephrol. 2024 Apr 26. doi: 10.1681/ASN.0000000000000361.
    PubMed     Abstract available
    
    
    
95. BABROUDI S, Weiner DE, Neyra JA, Drew DA, et al
    Acute Kidney Injury Receiving Dialysis and Dialysis Care following Hospital Discharge.
    J Am Soc Nephrol. 2024 Apr 23. doi: 10.1681/ASN.0000000000000383.
    PubMed     Abstract available
    
    
    
96. STEINER RW
    Equity in Preemptive Kidney Transplantation: The Case for Caution.
    J Am Soc Nephrol. 2024 Apr 8. doi: 10.1681/ASN.0000000000000347.
    PubMed    
    
    
    March 2024
97. KU E, McCulloch CE, Copeland TP, Johansen KL, et al
    Authors' Reply: Prioritizing Skills for Optimal Peritoneal Dialysis Care: A Focus Beyond Specialty.
    J Am Soc Nephrol. 2024;35:382-383.
    PubMed    
    
    
    
98. SAHUTOGLU T
    Prioritizing Skills for Optimal Peritoneal Dialysis Care: A Focus Beyond Specialty.
    J Am Soc Nephrol. 2024;35:381.
    PubMed    
    
    
    February 2024
99. ISMAIL S, Funk MJ, Flythe JE
    Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis.
    J Am Soc Nephrol. 2024 Feb 27. doi: 10.1681/ASN.0000000000000336.
    PubMed     Abstract available
    
    
    January 2024
100. ADLER JT, Kuk AE, Cron DC, Parast L, et al
     Insurance Transitions from Employer-Based Insurance to Medicare and Waitlisting for Kidney Transplantation: Placing Marietta v. DaVita in Context.
     J Am Soc Nephrol. 2024 Jan 15. doi: 10.1681/ASN.0000000000000298.
     PubMed    
     
     
     December 2023
101. HUSAIN SA
     Recentering Accountability for Disparities in Kidney Transplant Access.
     J Am Soc Nephrol. 2023 Dec 12. doi: 10.1681/ASN.0000000000000290.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum